Dysbiosis of the gut microbiome is associated with host health conditions. Many diseases
have shown to have correlations with imbalanced microbiota, including obesity …

Objective To systematically review and critically evaluate prediction models developed to
predict tuberculosis (TB) treatment outcomes among adults with pulmonary TB. Design …

Tuberculosis (TB) is the leading cause of death among infectious diseases, and the ratio of
cases in which its pathogen Mycobacterium tuberculosis (Mtb) is drug resistant has been …

Clinical symptoms of active tuberculosis (TB) can range from a simple cough to more severe
reactions, such as irreversible lung damage and, eventually, death, depending on disease …

Profound tuberculosis (TB)-induced metabolic changes reflected in the blood metabolomic
profile may provide an opportunity to identify specific markers of Mycobacterium tuberculosis …

Pediatric tuberculosis (TB) remains a major global health problem. Improved pediatric
diagnostics using readily available biosources are urgently needed. We used liquid …

The latest WHO report estimates about 1.6 million global deaths annually from TB, which is
further exacerbated by drug-resistant (DR) TB and comorbidities with diabetes and HIV …

Gut microbiota can either contribute to the host development and health, or lead to the
pathogenesis of various diseases in the case of imbalance. Microbial metabolites can act as …

Introduction Amid the global health crisis, HIV/TB co-infection presents significant
challenges, amplifying the burden on patients and healthcare systems alike. Metabolomics …

The highly adaptive cellular response of Mycobacterium tuberculosis to various antibiotics
and the high costs for clinical trials, hampers the development of novel antimicrobial agents …